NIH Notices

• Final NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
  (NOT-OD-16-094)
  National Institutes of Health
• Scenarios to Illustrate the Use of Direct and Indirect Costs for Single IRB Review under the NIH Policy on the Use of a Single IRB for Multi-site Research
  (NOT-OD-16-109)
  National Institutes of Health
• Notice of Pre-application Webinar for RFA-CA-15-014 Research Centers for the Cancer Systems Biology Consortium (U54)
  (NOT-CA-16-055)
  National Cancer Institute
• Notice of Change in Key Dates for PAR-16-201 "Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21)"
  (NOT-CA-16-056)
  National Cancer Institute
• Notice of Change in Key Dates for PAR-16-202 "Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01)"
  (NOT-CA-16-057)
  National Cancer Institute
• Request for Information (RFI): Transformative High-Resolution Cryo-Electron Microscopy
  (NOT-RM-16-022)
  NIH Roadmap Initiatives

NIH Requests for Applications

• U.S.-Russia Bilateral Collaborative Research Partnerships (CRP) on the Prevention and Treatment of HIV/AIDS and HIV-Associated Comorbidities (R01)
  (RFA-AA-17-006)
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 13, 2016, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.

NIH Program Announcements

• Methods Development in Natural Products Chemistry (R43/R44)
  (PA-16-341)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
• Methods Development in Natural Products Chemistry (R41/R42)
  (PA-16-342)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.

Other Funding or Opportunities

Title: Postdoctoral Fellowship (PDF) Grants - Basic and Translational Research
Sponsor: Susan G. Komen for the Cure
Upcoming Deadline: LOI: July 14, 2016.  Full Application (if invited): November 22, 2016
Abstract: The Letter of Intent must propose research that directly relates to breast cancer and clearly describes the significant potential to lead to reductions in breast cancer incidence and/or mortality within the next decade. 
Website: http://ww5.komen.org/ResearchGrants/FundingOpportunities.html 

Title: AACR-Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway
Sponsor: American Association for Cancer Research (AACR)
Upcoming Deadline: July 28, 2016
Abstract: The AACR - Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway represents a joint effort to encourage and support a postdoctoral or clinical research fellow to conduct cancer research on the HER Family Pathway and establish a successful career path in this field . The research proposed for funding may be basic, translational, or clinical in nature, and must have direct applicability to the HER Family Pathway in cancer.
Website: http://www.aacr.org/Funding/Pages/Funding-Detail.aspx?ItemID=22#.V2gDkvkrJhE

Title: Young Investigator Award (YIA)
Sponsor: American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation
Upcoming Deadline: September 22, 2016
Abstract: The YIA provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. The Conquer Cancer Foundation welcomes application submissions in all oncology subspecialties. The YIA is intended to support proposals with a clinical research focus. ASCO's definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease" Website: https://www.conquercancerfoundation.org/young-investigator-award

Title: Career Development Award (CDA)
Sponsor: American Society of Clinical Oncology (ASCO) Conquer Cancer Foundation
Upcoming Deadline: September 22, 2016
Abstract: The CDA provides funding to clinical investigators who have received their initial faculty appointment to establish an independent clinical cancer research program. The CDA is intended to support proposals with a clinical research focus. ASCO's definition of clinical research is "hypothesis-driven research that employs measurements in whole patients or normal human subjects, in conjunction with laboratory measurements as appropriate, on the subjects of clinical biology, natural history, prevention, screening, diagnosis, therapy, or epidemiology of neoplastic disease" Proposals must have a patient-oriented focus including a clinical research study involving human subjects. Proposals with a predominant focus on in vitro or animal studies (even if clinically relevant) are not allowed. Project proposals should have measurable outcomes during the grant period.
Website: https://www.conquercancerfoundation.org/career-development-award